Novacyt S.A. (CDI)

NCYT · AIM · Health Care · mcap £29m · 40.4p

Beta Briefing, track record and bull & bear case are not ready for Novacyt S.A. (CDI) yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 48 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 30 Sep 26 ↗

Revenue: £21.8m
Operating profit: −£26.5m
Net income: −£22.3m
Free cash flow: −£11.0m
Net cash: £8.9m
Market cap: £29.3m
EV / EBIT: –
FCF yield: −37.4%
Price / book: 1.6×

Latest half-year · H1 26 vs H1 25 results 30 Sep 26 ↗

Revenue: £11.6m
Operating profit: −£5.1m
Net income: −£5.8m
Cash from operations: −£4.6m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 30 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25	FY 24
Revenue	21.8	20.0	19.6
Gross profit	12.5	12.6	32.1
Operating profit	(26.5)	(28.5)	(37.3)
Profit before tax	(26.1)	(27.3)	(39.4)
Tax	3.7	3.9	0.7
Net income (owners)	(22.3)	(22.9)	(41.8)
Discontinued operations	0.1	0.6	(3.1)
EPS basic	(31.0p)	(32.0p)	(59.0p)
EPS diluted	(31.0p)	(32.0p)	(59.0p)

	H1 26	vs H1 25	H2 25	H1 25
Revenue	11.6	+18%	10.2	9.8
Gross profit	6.4	−1%	6.1	6.5
Adjusted EBITDA	(3.6)	n/m	–	(4.1)
EBITDA	(3.9)	n/m	–	(4.1)
Operating profit	(5.1)	n/m	(21.4)	(7.1)
Profit before tax	(5.8)	n/m	(20.3)	(7.0)
Tax	0.1	−63%	3.6	0.3
Net income (owners)	(5.8)	n/m	(16.5)	(6.3)
Discontinued operations	(0.1)	n/m	0.2	0.4
EPS basic	(8.0p)	–	(23.0p)	(9.0p)
EPS diluted	(8.0p)	–	(23.0p)	(9.0p)

	LTM Jun 26	FY 25	FY 24
Cash from operations	(8.3)	(9.2)	(9.8)
Capex (PP&E)	(0.2)	(0.3)	(1.3)
Capex (intangibles)	(0.5)	(0.6)	(0.6)
Lease principal paid	–	(1.9)	(1.9)
Share buybacks	–	(0.0)	0.0

	H1 26	vs H1 25	H2 25	H1 25
Cash from operations	(4.6)	n/m	(3.7)	(5.5)
Capex (PP&E)	(0.1)	−32%	(0.1)	(0.2)
Capex (intangibles)	(0.3)	−27%	(0.2)	(0.4)

	Latest Jun 26	FY 25	FY 24
Goodwill	4.4	2.2	2.7
Other intangibles	4.6	1.4	17.6
Property, plant & equipment	1.2	1.5	2.4
Inventories	4.5	2.5	2.3
Trade receivables	4.7	4.6	4.7
Cash	8.9	19.1	30.5
Current assets	20.0	27.7	39.4
Total assets	37.7	40.3	70.6
Trade payables	4.9	4.7	3.8
Lease liabilities, current	1.0	0.9	1.3
Current liabilities	6.4	5.8	6.2
Lease liabilities, non-current	9.2	9.6	10.6
Total liabilities	19.0	17.0	22.8
Total equity	18.7	23.4	47.9

	H1 26	H2 25	H2 24
Goodwill	4.4	2.2	2.7
Other intangibles	4.6	1.4	17.6
Property, plant & equipment	1.2	1.5	2.4
Inventories	4.5	2.5	2.3
Trade receivables	4.7	4.6	4.7
Cash	8.9	19.1	30.5
Current assets	20.0	27.7	39.4
Total assets	37.7	40.3	70.6
Trade payables	4.9	4.7	3.8
Lease liabilities, current	1.0	0.9	1.3
Current liabilities	6.4	5.8	6.2
Lease liabilities, non-current	9.2	9.6	10.6
Total liabilities	19.0	17.0	22.8
Total equity	18.7	23.4	47.9

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.